Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
131.00
-0.50 (-0.38%)
At close: Mar 27, 2026
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 11.1 billion as of March 27, 2026. Its market cap has decreased by -43.66% in one year.
Market Cap
11.10B
Enterprise Value
10.20B
Revenue
4.20B
Ranking
n/a
PE Ratio
10.69
Stock Price
131.00
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 11.10B, an increase of 1,003.91%. That is a compound annual growth rate of 14.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.10B | -10.27% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 237.54B |
| Caliway Biopharmaceuticals | 126.10B |
| Heron Neutron Medical | 61.90B |
| Bora Pharmaceuticals | 57.78B |
| Foresee Pharmaceuticals | 12.24B |
| TaiDoc Technology | 11.87B |
| Alar Pharmaceuticals | 11.36B |
| Vizionfocus | 11.24B |